Related Experiment Video
Updated: Jun 10, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
A novel method for diagnosing cirrhosis in patients with chronic hepatitis B: artificial neural network approach
Mohammad Reza Raoufy1, Parviz Vahdani, Seyed Moayed Alavian
1Department of Physiology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Insights
An artificial neural network (ANN) can accurately diagnose cirrhosis in chronic hepatitis B virus (HBV) patients using routine lab results. This non-invasive method offers a promising alternative to liver biopsy for detecting liver disease.
Area of Science:
- Hepatology
- Artificial Intelligence in Medicine
- Biostatistics
Background:
- Chronic hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide.
- Cirrhosis, a severe consequence of chronic HBV, requires accurate and timely diagnosis.
- Liver biopsy, the current gold standard for cirrhosis diagnosis, is invasive and carries risks.
Purpose of the Study:
- To develop and validate an artificial neural network (ANN) for non-invasive diagnosis of cirrhosis in patients with chronic HBV infection.
- To assess the diagnostic accuracy of the ANN using routine laboratory data.
- To compare the performance of the ANN with a traditional logistic regression model.
Main Methods:
- A dataset of 144 chronic HBV patients diagnosed with cirrhosis via liver biopsy was retrospectively analyzed.
- Routine laboratory parameters (PT, INR, platelet count, direct bilirubin, AST/ALT ratio, AST/PLT ratio) and patient age were collected.
- An artificial neural network (ANN) model was designed and trained using this data.
- Receiver-operating characteristic (ROC) analysis was employed to evaluate the ANN's diagnostic performance.
- Results were compared against a logistic regression model.
Main Results:
- The artificial neural network demonstrated high accuracy in diagnosing cirrhosis based on routine laboratory data.
- The ANN model showed superior performance compared to the logistic regression model in differentiating cirrhotic from non-cirrhotic patients.
- Key laboratory markers contributing to the ANN's diagnostic capability were identified.
Conclusions:
- Artificial neural network analysis offers a promising, non-invasive, and accurate method for diagnosing cirrhosis in chronic HBV-infected patients.
- The proposed ANN model, utilizing readily available laboratory data, can potentially reduce the need for invasive liver biopsies.
- This AI-driven approach could significantly improve the management and monitoring of liver disease in HBV patients.
Abstract:
We designed an artificial neural network (ANN) to diagnose cirrhosis in patients with chronic HBV infection. Routine laboratory data (PT, INR, platelet count, direct bilirubin, AST/ALT, AST/PLT) and age were collected from 144 patients. Cirrhosis in these patients was diagnosed by liver biopsy. The ANN's ability was assessed using receiver-operating characteristic (ROC) analysis and the results were compared with a logistic regression model. Our results indicate that the neural network analysis is likely to provide a non-invasive, accurate test for diagnosing cirrhosis in chronic HBV-infected patients, only based on routine laboratory data.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
